Journal of SAFOMS

Register      Login

VOLUME 1 , ISSUE 2 ( July-December, 2013 ) > List of Articles


Menopause—Nonhormonal Approach: What's New?

Urvashi Verma

Citation Information : Verma U. Menopause—Nonhormonal Approach: What's New?. J South Asian Feder Menopause Soc 2013; 1 (2):70-74.

DOI: 10.5005/jp-journals-10032-1016

Published Online: 01-12-2013

Copyright Statement:  Copyright © 2013; The Author(s).


PDF Share
  1. Understanding menopause. New Delhi: Jaypee Brothers Medical Publishers Pvt Ltd 2001. p 1-2.
  2. Jeffcoate's principal of gynaecology. Oxford: Butterworths-Heinemann Ltd; 2001. 106 p.
  3. Menopause: textbook of gynaecology. New Delhi: Jaypee Brothers Medical Publishers Pvt Ltd. 2011. 147 p.
  4. Menopause: current concepts. New Delhi, India: Jaypee Brothers Medical Publishers Pvt Ltd 2004. p. 8-9.
  5. Assessment of alpha 2 adrenergic autoreceptor function in humans: effects of oral yohimbine. Life Sci 1982 Jun 7;30(23):2033-2041.
  6. Treatment of menopausal hot flushes with nonhormonal medication, veralipride. Sem Hop 1982 Nov 11;58(41):2382-2384.
  7. Assessing risk and benefit of nonhormonal treatment for vasomotor symptoms in perimenopausal and post menopausal women. J Women's Health 2011 Jul;20(7):1007-1016.
  8. Efficacy of escitalopram for hot flushes in healthy menopausal women. JAMA 2011;305(3):267.
  9. Nonestrogen conventional and phytochemical treatment for vasomotor symptom: what need to be known for practice. Climacteric 2012 Apr;15(2):115-124.
  10. Alternative to the use of estrogen in postmenopausal women. Endocrine Rev 1999;20:308.
  11. Nonhormonal treatment strategy for vasomotor symptoms: a critical review. 2012 Feb;71(3):287-304.
  12. Complimentary and alternative therapies for the management of menopause related symptoms: a systematic evidence review. Arch Intern Med 2006;166:1453-1465.
  13. The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause 2012 Mar;19(3):257-271.
  14. Treatment of menopause associated symptoms: position statement of the North American Menopause Society. Menopause 2004;11:11-33.
  15. Management of menopause-associated vasomotor symptoms: current treatment options, challenges and future directions. Int J Womens Health 2010 Aug;2:123-135.
  16. Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha. Neuro Report 2002;13:1715-1720.
  17. Neuroprotective effect of Withania somnifera Dunn. in hippocampal sub-regions of female albino rat. Phytother Res 2001;15(6):544-548.
  18. Alternative medicine to HRT. Menopause: current concepts. New Delhi: Jaypee Brothers Medical Publishers Pvt Ltd. 2004. p. 155-166.
  19. FOGSI FOCUS. New Delhi: JDMPL. 2008 Jan. p. 80-86.
  20. Menopause: current concepts. Postmenopausal osteoporosis. New Delhi: Jaypee Brothers Medical Publishers Pvt Ltd; 2004.43. p.
  21. Osteoporosis treatment and atrial fibrillation: alendronate versus raloxifene. Menopause 2010;17(1):57-63.
  22. The relationship between blood mercury level and osteoporosis in postmenopausal women. Menopause 2012;19(5):576-581.
  23. Osteoporosis screening and guidelines are they being followed? Menopause 2011;18(10):1072-1078.
  24. Role of hormones in cartilage and joint metabolism: understanding an unhealthy metabolic phenotype in osteoarthritis. Menopause 2013 May;20(5):578-586.
  25. Soy isoflavones in the management of post menopausal osteoporosis. Menopause 2008 Jul-Aug;15(4 Pt 1):748-757.
  26. Tibolone. In: Kriplani A, Malhotra B, editors. Menopause current concept. 2nd ed. New Delhi: Jaypee Brothers Medical Publishers Pvt Ltd; 2006. pp. 134-143.
  27. Adolescent pregnancy is associated with osteoporosis in post menopausal women. Menopause 2012 Apr;19(4):456-460.
  28. Recombinant human PTH (1-3) fragment (rhPTH) reduces the risk of spine and nonspine fracture in postmenopausal osteoporosis. N Engl J Med 2001;344:1434-1441.
  29. Recombinant human parathyroid hormone (1-34) teriparatide improves both cortical and cancellous bone structure. J Bone Miner Res 2003;18(11):1932-1941.
  30. Does risk of anxiety increase during the menopausal transition? Study of women's health across the nation. Menopause 2013;20(5):488-495.
  31. Anxiety and menopausal transition-managing your expectations. Menopause 2013;20(5):481-482.
  32. Sexuality and aging: progress in obstetrics and gynecology. Vol 2. New Delhi: Jaypee Brothers Medical Publishers Pvt Ltd; 2004. 438 p.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.